Herold Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Herold Advisors's AMGN Position: Q2 2026 in Review
Herold Advisors reduced its Amgen (AMGN) stake by 2.7% in Q2 2026, selling an estimated $33.5K and leaving 3,526 shares worth $1.27M. The position accounts for 0.25% of the portfolio, ranked #100.
Herold Advisors first reported a position in AMGN in Q3 2021 and has held it in 17 quarters since. The position peaked at $1.71M in Q3 2024. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Herold Advisors held 3,526 shares of Amgen worth $1.27M as of Q2 2026.
- Herold Advisors sold 98 Amgen shares in Q2 2026, an estimated $33.5K.
- Amgen made up 0.25% of Herold Advisors's portfolio in Q2 2026, its #100 holding.
- Herold Advisors first reported a position in Amgen in Q3 2021 and has held it in 17 quarters since.
- Herold Advisors's Amgen position peaked at $1.71M in Q3 2024.
- 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Herold Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.